Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis

ZJ Madewell, Y Yang, IM Longini… - JAMA network …, 2022 - jamanetwork.com
Importance An overall household secondary attack rate (SAR) of 18.9%(95% CI, 16.2%-
22.0%) through June 17, 2021 was previously reported for SARS-CoV-2. Emerging variants …

[HTML][HTML] Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission

MW Russell, J Mestecky - Frontiers in immunology, 2022 - frontiersin.org
SARS-CoV-2 is primarily an airborne infection of the upper respiratory tract, which on
reaching the lungs causes the severe acute respiratory disease, COVID-19. Its first contact …

Population-level implications of the Israeli booster campaign to curtail COVID-19 resurgence

N Gavish, R Yaari, A Huppert, G Katriel - Science translational medicine, 2022 - science.org
Israel was one of the first countries to administer mass vaccination against severe acute
respiratory syndrome coronavirus 2. Consequently, it was among the first countries to …

[HTML][HTML] Maternal third dose of BNT162b2 mRNA vaccine and risk of infant COVID-19 hospitalization

M Lipschuetz, J Guedalia, SM Cohen, Y Sompolinsky… - Nature Medicine, 2023 - nature.com
Infants are at a higher risk of Coronavirus Disease 2019 (COVID-19)-related hospitalizations
compared to older children. In this study, we investigated the effect of the recommended …

A single-administration therapeutic interfering particle reduces SARS-CoV-2 viral shedding and pathogenesis in hamsters

S Chaturvedi, N Beutler, G Vasen… - Proceedings of the …, 2022 - National Acad Sciences
The high transmissibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
is a primary driver of the COVID-19 pandemic. While existing interventions prevent severe …

[HTML][HTML] Increased secondary attack rates among the household contacts of patients with the Omicron variant of the coronavirus disease 2019 in Japan

T Ogata, H Tanaka, E Tanaka, N Osaki… - International Journal of …, 2022 - mdpi.com
This study investigated the household secondary attack rate (HSAR) of patients with
coronavirus disease (COVID-19) during the omicron variant-dominant period. The HSAR of …

[HTML][HTML] Effectiveness of COVID-19 vaccination on transmission: A systematic review

A Oordt-Speets, J Spinardi, C Mendoza, J Yang… - COVID, 2023 - mdpi.com
Vaccination against infectious disease affords direct protection from vaccine-induced
immunity and additional indirect protection for unvaccinated persons. A systematic review …

[HTML][HTML] COVID-19 vaccine efficacy and immunogenicity in end-stage renal disease patients and kidney transplant recipients

NF Moreno, R McAdams, JA Goss… - Current Transplantation …, 2022 - Springer
Abstract Purpose of Review To summarize the current literature with respect to COVID-19
vaccine efficacy patients with end-stage renal disease on dialysis and kidney transplant …

[HTML][HTML] Strategies and safety considerations of booster vaccination in COVID-19

H Meng, J Mao, Q Ye - Bosnian Journal of Basic Medical Sciences, 2022 - ncbi.nlm.nih.gov
The first-generation SARS-CoV-2 vaccines have played a significant role in controlling the
COVID-19 pandemic, preventing severe diseases, and reducing mortality. However, the …

[HTML][HTML] Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March–October, 2021

ID Plumb, LM Fette, AH Tjaden, L Feldstein, S Saydah… - Vaccine, 2023 - Elsevier
Background Monitoring the effectiveness of COVID-19 vaccines against SARS-CoV-2
infections remains important to inform public health responses. Estimation of vaccine …